Rocket Lab Corporation $RKLB Stock: Sumitomo Mitsui Trust Group Inc. Grows Holdings

Sumitomo Mitsui Trust Group Inc. boosted its stake in Rocket Lab Corporation (NASDAQ:RKLB) by 43.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,235,469 shares of the rocket manufacturer’s stock after buying an additional 678,342 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Rocket Lab were worth $155,767,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in Rocket Lab during the 2nd quarter worth $4,124,970,000. Katamaran Capital LLP raised its position in shares of Rocket Lab by 86.2% in the first quarter. Katamaran Capital LLP now owns 19,808 shares of the rocket manufacturer’s stock valued at $1,272,000 after buying an additional 9,172 shares during the last quarter. Y.D. More Investments Ltd purchased a new position in shares of Rocket Lab in the first quarter worth about $642,000. Swiss National Bank lifted its stake in shares of Rocket Lab by 17.8% in the first quarter. Swiss National Bank now owns 1,410,930 shares of the rocket manufacturer’s stock worth $90,610,000 after buying an additional 212,700 shares in the last quarter. Finally, Bank of Nova Scotia boosted its position in Rocket Lab by 149.8% during the first quarter. Bank of Nova Scotia now owns 49,957 shares of the rocket manufacturer’s stock worth $3,209,000 after acquiring an additional 29,956 shares during the last quarter. 71.78% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Frank Klein sold 45,692 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $3,181,533.96. Following the completion of the sale, the insider owned 961,295 shares in the company, valued at $66,934,970.85. This trade represents a 4.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the sale, the chief accounting officer owned 26,863 shares of the company’s stock, valued at $1,870,470.69. This represents a 2.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 400,749 shares of company stock worth $26,964,474 over the last ninety days. 8.40% of the stock is currently owned by insiders.

Rocket Lab Price Performance

NASDAQ RKLB opened at $54.73 on Monday. The business’s fifty day simple moving average is $64.23 and its 200-day simple moving average is $79.93. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The firm has a market cap of $32.75 billion, a PE ratio of -202.70 and a beta of 3.15. Rocket Lab Corporation has a 52 week low of $37.57 and a 52 week high of $151.00.

Rocket Lab (NASDAQ:RKLB) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. As a group, equities analysts anticipate that Rocket Lab Corporation will post -0.20 earnings per share for the current year.

Analyst Ratings Changes

RKLB has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a research note on Thursday, October 15th. Raymond James Financial assumed coverage on shares of Rocket Lab in a research note on Friday, September 11th. They issued an “outperform” rating and a $80.00 target price on the stock. KeyCorp lowered their target price on Rocket Lab from $135.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday, October 15th. Morgan Stanley restated an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Finally, Cantor Fitzgerald restated a “mixed” rating and issued a $122.00 price target on shares of Rocket Lab in a research report on Thursday, October 15th. Three analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Rocket Lab has an average rating of “Moderate Buy” and a consensus target price of $102.05.

More Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.